Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CV Sciences (CVSI)
:CVSI
Holding CVSI?
Track your performance easily
CVSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.10
Previous CloseN/A
Volume110.38K
Average Volume (3M)334.61K
Market Cap
$6.64M
Enterprise Value$8.26M
Total Cash (Recent Filing)$781.86K
Total Debt (Recent Filing)$679.17K
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding184,263,660
10 Day Avg. Volume325,654
30 Day Avg. Volume334,613
Standard Deviation0.23
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)-16.60
P/FCF Ratio0.00
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit1.17
Enterprise Value/Ebitda-5.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CV Sciences News
PremiumCompany Announcements
CV Sciences to Acquire Extract Labs for Growth
Options Prices
Currently, No data available
---
Ownership Overview
0.02%
Insiders
<0.01% Other Institutional Investors
99.98% Public Companies and
Individual Investors
CVSI FAQ
What was CV Sciences’s price range in the past 12 months?
CV Sciences lowest stock price was $0.03 and its highest was $0.10 in the past 12 months.
What is CV Sciences’s market cap?
CV Sciences’s market cap is $6.64M.
When is CV Sciences’s upcoming earnings report date?
CV Sciences’s upcoming earnings report date is Mar 27, 2025 which is in 68 days.
How were CV Sciences’s earnings last quarter?
CV Sciences released its earnings results on Nov 14, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is CV Sciences overvalued?
According to Wall Street analysts CV Sciences’s price is currently Overvalued.
Does CV Sciences pay dividends?
CV Sciences does not currently pay dividends.
What is CV Sciences’s EPS estimate?
CV Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CV Sciences have?
CV Sciences has 184,263,660 shares outstanding.
What happened to CV Sciences’s price movement after its last earnings report?
CV Sciences reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CV Sciences?
Currently, no hedge funds are holding shares in CVSI
---
Company Description
CV Sciences
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California.
---
CVSI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of steady performance in revenue and gross margins, successful product launches, and strategic acquisitions. However, the company faces challenges such as a decline in unit sales, revenue impact from regulatory changes in California, and a slight decrease in cash reserves. The sentiment remains cautiously optimistic due to the company's market leadership and strategic initiatives.Read More>---
Technical Analysis
General Cannabis
―
Medical Marijuana
―
Cannabis Sativa
―
CNBX Pharmaceuticals
―
Hemp
―
Canopy Growth
―
---